High glucose concentration in cell culture medium does not acutely affect human mesenchymal stem cell growth factor production or proliferation
- 1 June 2009
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 296 (6), R1735-R1743
- https://doi.org/10.1152/ajpregu.90876.2008
Abstract
Optimizing the function and proliferative capacity of stem cells is essential to maximize their therapeutic benefits. High glucose concentrations are known to have detrimental effects on many cell types. We hypothesized that human mesenchymal stem cells (hMSCs) cultured in high glucose-containing media would exhibit diminished proliferation and attenuated production of VEGF, hepatocyte growth factor (HGF), and FGF2 in response to treatment with TNF-α, LPS, or hypoxia. hMSCs were plated in medium containing low (5.5 mM) and high (20 mM or 30 mM) glucose concentrations and treated with TNF-α, LPS, or hypoxia. Supernatants were collected at 24 and 48 h and assayed via ELISA for VEGF, HGF, and FGF2. In addition, hMSCs were cultured on 96-well plates at the above glucose concentrations, and proliferation at 48 h was determined via bromo-2′-deoxy-uridine (BrdU) incorporation. At 24 and 48 h, TNF-α, LPS, and hypoxia-treated hMSCs produced significantly higher VEGF, HGF, and FGF2 compared with control. Hypoxia-induced VEGF production by hMSCs was the most pronounced change over baseline. At both 24 and 48 h, glucose concentration did not affect production of VEGF, HGF, or FGF2 by untreated hMSCs and those treated with TNF-α, LPS, or hypoxia. Proliferation of hMSCs as determined via BrdU incorporation was unaffected by glucose concentration of the media. Contrary to what has been observed with other cells, hMSCs may be resistant to the short-term effects of high glucose. Ongoing efforts to characterize and optimize ex vivo and in vivo conditions are critical if the therapeutic benefits of MSCs are to be maximized.Keywords
This publication has 48 references indexed in Scilit:
- VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell functionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actionsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2-mediated pathwaysAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- TGF-α increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K- but not JNK- or ERK-dependent mechanismsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Surgically relevant aspects of stem cell paracrine effectsSurgery, 2008
- Effects of high glucose on mesenchymal stem cell proliferation and differentiationBiochemical and Biophysical Research Communications, 2007
- STAT3 mediates bone marrow mesenchymal stem cell VEGF productionJournal of Molecular and Cellular Cardiology, 2007
- Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1αJCI Insight, 2007
- In vitro and in vivo effects of bone marrow stem cells on cardiac structure and functionJournal of Molecular and Cellular Cardiology, 2007
- Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal CellsCirculation, 2004